Senthilkumar S Karuppagounder

9PUBLICATIONS
98CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsGenetically modified animalsCellular nervous systemPacific Peoples sport and physical activity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 29, 2023
Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson's disease.

Mohammed Repon Khan, Xiling Yin, Sung-Ung Kang

|Sep 20, 2023
A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke.

Patrick D Lyden, Márcio A Diniz, Francesca Bosetti

|Jan 18, 2023
The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.

Senthilkumar S Karuppagounder, Hu Wang, Terence Kelly

|Oct 24, 2022
The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgAD257A/D257A Mitochondrial Mutator Mice.

Laura Scott, Senthilkumar S Karuppagounder, Stewart Neifert

|Mar 31, 2022
The Stroke Preclinical Assessment Network: Rationale, Design, Feasibility, and Stage 1 Results.

Patrick D Lyden, Francesca Bosetti, Márcio A Diniz

|Jul 29, 2021
PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease.

Areum Jo, Yunjong Lee, Tae-In Kam

Pageof 2